Sinônimos:4-[(3-endo)-3-Hydroxy-8-azabicyclo[3.2.1]oct-8-yl]naphthalene-1-carbonitrile;AC-262536;AC-262,356;4-(3-endo-Hydroxy-8-azabicyclo[3.2.1]oct-8-yl)naphthalene-1-carbonitrile
Other names: AC-262 356/AC-262,356 Sarms/AC-262356
CAS:870888-46-3
MF:C18H18N2O
storage temp. 2-8°C
AC-262.536 é um medicamento que atua como modulador seletivo do receptor andrógeno. Quimicamente possui isomeria endo-exo, com a forma endo sendo a forma ativa. Atua como agonista parcial do receptor andrógeno com Ki de 5nM, e nenhuma afinidade significativa para quaisquer outros receptores testados. Em estudos com animais, produziu um efeito máximo de cerca de 66% of the anabolic action of test osterone, but only around 27% of its potency as an androgen.
AC-262536 is a drug developed by Acadia Pharmaceuticals which acts as a selective androgen receptor modulator (SARM).
Quimicamente possui isomeria endo-exo, com a forma endo sendo a forma ativa. Atua como agonista parcial do receptor andrógeno com Ki de 5nM, e nenhuma afinidade significativa para quaisquer outros receptores testados. Em estudos com animais, produziu um efeito máximo de cerca de 66% of the anabolic action of testosterone, but only around 27% of its potency as an androgen.
1.helping improve the function of the hippocampus (which could stave off the onset of Alzheimer’s disease)
and the possible prevention of prostate cancer. Tests data reveal that this SARM can suppress the activity of dihydroxytestosterone (DHT) in the human prostate cancer cell.
2.Scientists also found out that AC-262,536’s effects in keeping the prostate’s ideal size were 14x weaker than that of testosterone.
3.Acts On Pituitary Function
4.Helps With Muscle Growth
5.May Help With Alzheimer’s Disease
